Eaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine.
- 1 November 1980
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 43 (11), 978-985
- https://doi.org/10.1136/jnnp.43.11.978
Abstract
In a patient with the Eaton-Lambert syndrome, 4-aminopyridine produced temporary improvement of clinical and electromyographic abnormalities. Application of the drug in vitro to intercostal muscle from the patient produced an increase in the evoked release of neurotransmitter from intramuscular nerves.This publication has 31 references indexed in Scilit:
- Facilitatory effects of 4‐aminopyridine on normal neuromuscular transmissionMuscle & Nerve, 1980
- Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease statesMuscle & Nerve, 1980
- Effect of temperature on neuromuscular transmission in the Eaton-Lambert syndromeJournal of Neurology, Neurosurgery & Psychiatry, 1979
- Effects of 4-aminopyridine in myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1979
- Short report: 4-Aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndromeJournal of Neurology, Neurosurgery & Psychiatry, 1977
- Dynamics of aminopyridine block of potassium channels in squid axon membrane.The Journal of general physiology, 1976
- An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravisExperimental Neurology, 1976
- Diagnostic difficulties encountered in the myasthenic syndrome sometimes associated with carcinomaJournal of Neurology, Neurosurgery & Psychiatry, 1974
- QUANTAL COMPONENTS OF END‐PLATE POTENTIALS IN THE MYASTHENIC SYNDROME*Annals of the New York Academy of Sciences, 1971
- DEFECTS OF NEUROMUSCULAR TRANSMISSION IN SYNDROMES OTHER THAN MYASTHENIA GRAVISAnnals of the New York Academy of Sciences, 1966